Molecular Modeling Studies, Synthesis and Biological Evaluation of Novel Plasmodium falciparum Lactate Dehydrogenase (pfLDH) Inhibitors
Premlata Ambre(Bombay College of Pharmacy), Evans C. Coutinho(Bombay College of Pharmacy), Abhai K. Tripathi(Johns Hopkins University), David Sullivan(Johns Hopkins University), Livia Vivas(London School of Hygiene & Tropical Medicine), Ashish S. Jagyasi, K. R. Krishna Iyer(University of Michigan), Richard W. Birkinshaw(The University of Melbourne), Vijay M. Khedkar(National Chemical Laboratory), Raghuvir R. S. Pissurlenkar(Bombay College of Pharmacy), Chandrashekar R. Barhate, Ritesh A. Fule, R.L. Brady(Bristol Institute for Transfusion Sciences)
Cited by 2
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
|Journal of Clinical Investigation|2020|480
Inactivation of Cytochrome P450 3A4 by Bergamottin, a Component of Grapefruit Juice
|Chemical Research in Toxicology|1998|312
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
|Journal of Clinical Investigation|2021|276
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
|New England Journal of Medicine|2022|269